FdaApplication
ANDA 210128
Identifiers
- fda_app_no: ANDA210128
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2019-12-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APIXABAN | APIXABAN | 2.5MG | TABLET;ORAL |
| APIXABAN | APIXABAN | 5MG | TABLET;ORAL |
2 products